-
Innovation Ranking
Innovation Ranking – OC Oerlikon Corporation AG
OC Oerlikon Corporation AG (Oerlikon) is a provider of advanced materials, surface solutions and materials processing. It develops production systems, components, and services for high-technology products; and provides turnkey solutions for the manufacturing of protective coatings for precision tools and components, and equipment for textile production and propulsion technology. Oerlikon serves customers in aerospace, automotive, general industries and tooling, energy, apparel and industrial textiles, and agriculture sectors in Europe, Asia-Pacific, North America and other regions. The company has sales, service...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OC-001 in Merkel Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OC-001 in Merkel Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OC-001 in Merkel Cell Carcinoma Drug Details: OC-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OC-001 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OC-001 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OC-001 in Triple-Negative Breast Cancer (TNBC) Drug Details: OC-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Cystoid Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexamethasone Acetate in Cystoid Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Cystoid Macular Edema Drug Details: Dexamethasone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Ocular Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexamethasone Acetate in Ocular Inflammation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Ocular Inflammation Drug Details: Dexamethasone acetate (DexNP,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Ocular Pain (Eye Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexamethasone Acetate in Ocular Pain (Eye Pain) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Ocular Pain (Eye Pain) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Licaminlimab in Anterior Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Licaminlimab in Anterior Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Licaminlimab in Anterior Uveitis Drug Details: Licaminlimab (OCS-02) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OCE-205 in Ascites
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OCE-205 in Ascites report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OCE-205 in Ascites Drug Details: OCE-205 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EVT-801 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EVT-801 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EVT-801 in Pancreatic Cancer Drug Details: EVT-801 is a small molecule,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EVT-801 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EVT-801 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EVT-801 in Ovarian Cancer Drug Details: EVT-801 is a small molecule,...